The U.S. government said on Wednesday it will consider opportunities to "bring greater transparency" for the Medicare drug ...

Bhanvi Satija reports on pharmaceutical companies and the healthcare industry in the United States. She has a postgraduate degree in International Journalism from City, University of London.

By Patrick Wingrove and Bhanvi Satija (Reuters) -Johnson & Johnson, fresh off a $14.6 billion deal to buy neurological ...

The U.S. Food and Drug Administration approved Johnson & Johnson's ketamine-based nasal spray Spravato to treat adults with ...

Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss treatment Wegovy are among the 15 drugs targeted for ...